Fig. 4From: Successful management of severe asthma in a young boy with eosinophilic chronic rhinosinusitis who received omalizumab: a case reportClinical course and laboratory findings. A timeline of the treatments, symptoms, IgE levels, eosinophil counts, and %FEV1.0 is presented. PSL prednisolone, ICS/LABA inhaled long-acting β-agonist/corticosteroid, CsA cyclosporine, BIS budesonide inhalation suspension, FP fluticasone propionate, SLM salmeterol xinafoate, ESS endoscopic sinus surgeryBack to article page